Home > Physicians > Kim, Terry

Terry Kim, MD

Terry Kim, MD, Associate Director, Cornea and Refractive Surgery Services

Associate Director, Cornea and Refractive Surgery Services

Department / Division:
Ophthalmology / Cornea and External Disease

Address:
DUMC 3802
Durham, NC 27710

Appointment Telephone:
(919) 681-3937

Office Telephone:
(919) 681-3568

Fax Telephone:
(919) 681-7661

Training:
  • M.D., Duke University School of Medicine, North Carolina, 1992

Residency:
  • Ophthalmology, Emory University School of Medicine, Georgia, 1993-1996

Fellowship:
  • Cornea and Refractive Surgery, Wills Eye Hospital, Pennsylvania, 1996-1997

Clinical Interests:
Corneal transplantation, PK, DSEK, cataract surgery, multifocal IOL, ReSTOR, laser refractive surgery, LASIK, LASEK, PRK, thin-flap LASIK, IntraLASIK, Intralase, femtosecond laser, phakic IOL, Verisys, Visian ICL

Research Interests:
My clinical research and basic science research will now focus on two projects, both of which will receive NIH/NEI funding.  My first project will involve the potential clinical applications of new corneal adhesives know as biodendrimers.  These new and unique molecules will be developed and synthesized by Dr. Mark Grinstaff of the Chemistry Department here at Duke University.  They will then be tested in an in vitro (human eyebank eyes) and in vivo (chicken eyes) setting to study adhesive behavior and effectivenes. Some biodendrimers have already been tested and found to have many advantages over traditional cyanoacrylate adhesives.  Hopefully, these new biodendrimers will offer a new approach to the repair of corneal wounds, including corneal lacerations. LASIK flaps, and corneal transplants.

My second focus will involve investigating the potential anterior segment applications of a newly developed modification on optical coherence tomography (OCT).  This new real-time OCT technology has not been applied to anterior segment conditions of the eye.  Specifically, we plan to study the changes that occur in the eye during accommodation with regard to anterior lens contour and ciliary body/iris position.  We also plan to apply this new technology to assess the position and help determine the sizing of various posterior chamber phakic intraocular lenses.

Otherwise, I will continue with my clinical research interests involving the effective of refractive surgery (i.e. LASIK) on the corneal endothelium.  I also plan to continue my collaborative studies with Dr. Henry Edelhauser of Emory Eye Center looking at the effects of various intraocular medications (i.e. Alphagan) on the corneal endothelium.

Representative Publications:
Kim T, Palay DA, Lynn M. Donor Factors Associated with Epithelial Defects after Penetrating Keratoplasty. Cornea 1996; 15(5): 451-456. (1996)

Patel NP, Kim T, Rapuano CJ, Cohen EJ, Laibson PR. Indications for and Outcomes of Repeat Penetrating Keratoplasty, 1989 - 1995. Ophthalmology 2000; 107(4):719-724. (1995)

Kim T, Holley GP, Lee JH, Broocker G, Edelhauser HF. The Effects of Intraocular Lidocaine on the Corneal Endothelium. Ophthalmology 1998; 105(1):125-130. (1998)

Kim T, Cohen EJ, Schnall BM, Affell EL, Eagle RC. Ultrasound Biomicroscopy and Histopathology of Sclerocornea. Cornea 1998; 17(4):444-6. (1998)

Kim T, Sorenson AL. Bilateral Descemet's Membrane Detachments. Arch Ophthalmol 2000; 119(9):1302-1303. (2000)